Bectumomab

{{Short description|Chemical compound}}

{{Drugbox

| Verifiedfields = changed

| verifiedrevid = 459526771

| type = mab

| mab_type = Fab'

| source = o

| target = CD22

| tradename = LymphoScan

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number_Ref = {{cascite|changed|??}}

| CAS_number = 158318-63-9

| ATC_prefix = none

| ATC_suffix =

| PubChem =

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}

| ChemSpiderID = none

| chemical_formula =

| molecular_weight =

}}

Bectumomab (marketed under the trade name LymphoScan) is a mouse monoclonal antibody labelled with the radioactive isotope technetium-99m. It is used to detect non-Hodgkin's lymphoma.{{Cite web |url=http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list75.pdf |title=WHO Drug Information |access-date=2009-09-23 |archive-url=https://web.archive.org/web/20110604232319/http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list75.pdf |archive-date=2011-06-04 |url-status=dead }}{{cite journal | vauthors = Lamonica D, Czuczman M, Nabi H, Klippenstein D, Grossman Z | title = Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL) | journal = Cancer Biotherapy & Radiopharmaceuticals | volume = 17 | issue = 6 | pages = 689–97 | date = December 2002 | pmid = 12537673 | doi = 10.1089/108497802320970307 | url = http://cat.inist.fr/?aModele=afficheN&cpsidt=14422885 }}